Relmada Therapeutics, Inc. (RLMD)
4.42
+0.28
(+6.76%)
USD |
NASDAQ |
Dec 10, 16:00
4.50
+0.08
(+1.81%)
After-Hours: 20:00
Relmada Therapeutics Total Assets (Quarterly): 14.88M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Puma Biotechnology, Inc. | 202.86M |
| Sensus Healthcare, Inc. | 58.30M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.411M |
| Shareholders Equity (Quarterly) | 9.466M |
| Current Ratio | 2.862 |